EORTC CLTF 2018 | Insight into CTCL intratumor heterogeneity may inform disease management

Robert Gniadecki

Robert Gniadecki, MD, PhD, of the University of Alberta, Edmonton, Canada, explores how mutation distribution in cutaneous T-cell lymphoma translates into clinically significant data. This video was recorded at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland.

Share this video  
Similar topics
Related videos
Venetoclax monotherapy for relapsed/refractory Waldenström’s macroglobulinemia
Jorge Castillo
Waldenström's PFS unaffected by ibrutinib dose reduction, for now
Jorge Castillo
Anti-CD19 CAR T-cell therapy in combination with ibrutinib for CLL/SLL
Saar Gill
Waldenström’s macroglobulinemia: a link between institution visited and survival
Stephen Ansell
1:17
CART19-BE-01 trial: next-generation CAR T-cell therapy for CD19+ R/R leukemia and lymphoma
Valentín Ortiz-Maldonado
Cutaneous T-Cell Lymphoma, Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma
EORTC CLTF 2018
Interview
27th September 2018
More from Robert Gniadecki
High-throughput sequencing to inform mycosis fungoides management
ECP experience in Canada: prospects and challenges
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals